Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Brief: Takara Bio to start phase I/II clinical trials of gene therapy for sarcoma treatment

Jan 24 (Reuters) - Takara Bio Inc    4974.T : 
     
     
    * Says the co to start phase I/II clinical trials of gene 
therapy for treatment of sarcoma 
     
     
    Source text in Japanese:https://goo.gl/m8cqDF 
    Further company coverage: 4974.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724; 
Reuters Messaging: jun.cao.reuters.com@reuters.net))

Recent news on Takara Bio

See all news